We are live on ! Find out more
BIOC

Biocept, Inc.
BIOC

Delisted

BIOC was delisted on the 24th of October, 2023.

Back to rankings

20 hedge funds and large institutions have $9.75M invested in Biocept, Inc. in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,089% more capital invested

Capital invested by funds: $820K → $9.75M (+$8.93M)

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

7.6% more ownership

Funds ownership: 2.85% → 10.45% (+7.6%)

5% more funds holding

Funds holding: 19 → 20 (+1)

Holders
20
Holders Change
+1
Holders Change %
+5.26%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.87M
2
BlackRock
BlackRock
New York
+$1.18M
3
Renaissance Technologies
Renaissance Technologies
New York
+$943K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$118K
5
Northern Trust
Northern Trust
Illinois
+$111K

Top Sellers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
-$63K
2
UBS Group
UBS Group
Switzerland
-$35.9K
3
Citadel Advisors
Citadel Advisors
Florida
-$12K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9K
5
HF
HRT Financial
New York
-$8K

BIOC Hedge Fund Activity: Q2 2020 in Review

20 of the 4,889 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q2 2020, worth a combined $9.75M — up 1,089% from $820K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BIOC positions and 5 closed out — a net gain of 1 holder — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.87M. The largest seller was Barclays, exiting entirely with an estimated $63K sold.

  • 20 institutional investors held Biocept, Inc. (BIOC) as of Q2 2020, up from 19 in Q1 2020.
  • Funds reported $9.75M of Biocept, Inc. stock for Q2 2020, up 1,089% quarter-over-quarter.
  • 6 funds opened new Biocept, Inc. positions in Q2 2020 and 5 closed out, a net change of +1 holder.
  • The largest Biocept, Inc. buyer in Q2 2020 was Vanguard Group, an estimated $2.87M added.
  • The largest Biocept, Inc. seller in Q2 2020 was Barclays, an estimated $63K sold.

Based on aggregated 13F filings for Q2 2020.